More on BVTI
Data
Financials
News
Click line-items for a historical chart and %
| Products | 288K |
| Services | 234K |
| Qualified Therapeutic Discovery Project Grant | |
| Total revenue | 522K |
| Products | 274K |
| Services | 111K |
| Research and development expense | 1.45M |
| General and administrative expense | 780K |
| Total operating costs and expenses | 2.61M |
| Loss from operations | -2.09M |
| Interest expense, net | -10K |
| Gain (Loss) on derivative liabilities | 0 |
| Other (expense)/income, net | 0 |
| Total other (expense)/income | -10K |
| Income/(Loss) before reorganization items, non-controlling interest in losses from variable interest entities and income taxes | |
| Gain on reorganization | |
| Professional fees | |
| Provision for indemnity agreements | |
| Total reorganization items | |
| Net Income (Loss) | -2.1M |
| Less: Net loss attributable to non-controlling interests | -5K |
| Net income (loss) attributable to Biovest International, Inc | -2.09M |
| Basic | |
| Diluted | |
| Basic | |
| Diluted | |
